Public attention on ibogaine was renewed following the death of 27-year-old Presley Gerber, who had traveled to Mexico for high-dose treatment while struggling with addiction.

Mind-altering substances like psilocybin, LSD, MDMA, and ayahuasca and their therapeutic and cultural use.

First government-funded clinical trials of ibogaine for opioid addiction and PTSD, conducted by the FDA and VA.